TY  - GEN
AU  - Dubsky,P
AU  - Brase,J C
AU  - Jakesz,R
AU  - Rudas,M
AU  - Singer,C F
AU  - Greil,R
AU  - Dietze,O
AU  - Luisser,I
AU  - Klug,E
AU  - Sedivy,R
AU  - Bachner,M
AU  - Mayr,D
AU  - Schmidt,M
AU  - Gehrmann,M C
AU  - Petry,C
AU  - Weber,K E
AU  - Fisch,K
AU  - Kronenwett,R
AU  - Gnant,M
AU  - Filipits,M
TI  - The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients
SN  - 1532-1827
PY  - 2014///0509
KW  - Anastrozole
KW  - Antineoplastic Agents, Hormonal
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Differentiation
KW  - physiology
KW  - Cell Growth Processes
KW  - Clinical Trials, Phase III as Topic
KW  - Female
KW  - Gene Expression Profiling
KW  - Humans
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Nitriles
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Randomized Controlled Trials as Topic
KW  - Receptor, ErbB-2
KW  - biosynthesis
KW  - Receptors, Estrogen
KW  - Retrospective Studies
KW  - Signal Transduction
KW  - Tamoxifen
KW  - Treatment Outcome
KW  - Triazoles
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/bjc.2013.671
ER  -